PAB 0.00% 0.4¢ patrys limited

Ann: CBCF funding to support deoxymab brain cancer development, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,332 Posts.
    lightbulb Created with Sketch. 957
    Rereading this exciting Ann from Friday the one line that really stood out for me was

    ""To have a ground-breaking antibody that can potentially be in clinic by 2023 is life changing""

    Now i know the sceptics will pounce on the word "potentially" but if we can get our antibody into the clinic by 2023 what would PAB's SP be by then?

    There will be deals done everywhere with our IP and the big boys will be scrambling overthemselves to have a bigger piece of this as they can, which will help our VP and CEO push the value of PAB to a scale of SP i only dare to dream about..

    End of 2023 for life changing developments which will go hand in hand with lifetime wealth who stayed the course......

    What a ""potentially"life changing year we could all have.....

    Good Luck

    TICK TOCK
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.229M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
10 25958308 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 8632908 14
View Market Depth
Last trade - 13.05pm 18/11/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.